Morphological predictors of BRCA1 germline mutations in young women with breast cancer
Open Access
- 22 February 2011
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 104 (6) , 903-909
Abstract
Knowing a young woman with newly diagnosed breast cancer has a germline BRCA1 mutation informs her clinical management and that of her relatives. We sought an optimal strategy for identifying carriers using family history, breast cancer morphology and hormone receptor status data. We studied a population-based sample of 452 Australian women with invasive breast cancer diagnosed before age 40 years for whom we conducted extensive germline mutation testing (29 carried a BRCA1 mutation) and a systematic pathology review, and collected three-generational family history and tumour ER and PR status. Predictors of mutation status were identified using multiple logistic regression. Areas under receiver operator characteristic (ROC) curves were estimated using five-fold stratified cross-validation. The probability of being a BRCA1 mutation carrier increased with number of selected histology features even after adjusting for family history and ER and PR status (PP=0.001); 7.8 (2.7–25.7) for mitotic index over 50 mitoses per 10 high-powered field (P=0.0003); and 2.7 (1.3–5.9) for each first-degree relative with breast cancer diagnosed before age 60 years (P=0.01).The area under the ROC curve was 0.87 (0.83–0.90). Pathology review, with attention to a few specific morphological features of invasive breast cancers, can identify almost all BRCA1 germline mutation carriers among women with early-onset breast cancer without taking into account family history.Keywords
This publication has 43 references indexed in Scilit:
- Incorporating tumour pathology information into breast cancer risk prediction algorithmsBreast Cancer Research, 2010
- Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomyBreast Cancer Research and Treatment, 2010
- BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative researchBreast Cancer Research and Treatment, 2008
- Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinicsJournal of Medical Genetics, 2008
- The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensionsBritish Journal of Cancer, 2008
- BRCA1 promoter deletions in young women with breast cancer and a strong family history: A population-based studyEuropean Journal of Cancer, 2007
- First Amsterdam, Then Bethesda, Now Melbourne?Journal of Clinical Oncology, 2005
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesThe American Journal of Human Genetics, 2003
- Tumour biological features of BRCA1-induced breast and ovarian cancerEuropean Journal of Cancer, 1997
- Estimating the Dimension of a ModelThe Annals of Statistics, 1978